Assertio Therapeutics Long Term Debt To Capitalization Over Time

ASRT Stock  USD 0.93  0.01  1.06%   
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Assertio Therapeutics Performance and Assertio Therapeutics Correlation.
For more information on how to buy Assertio Stock please use our How to Invest in Assertio Therapeutics guide.
  
Long Term Debt To Capitalization is likely to gain to 0.34 in 2024.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assertio Therapeutics. If investors know Assertio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Assertio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.19)
Earnings Share
(4.94)
Revenue Per Share
1.322
Quarterly Revenue Growth
(0.18)
Return On Assets
(0.01)
The market value of Assertio Therapeutics is measured differently than its book value, which is the value of Assertio that is recorded on the company's balance sheet. Investors also form their own opinion of Assertio Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Assertio Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Assertio Therapeutics' market value can be influenced by many factors that don't directly affect Assertio Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Assertio Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Assertio Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Assertio Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Specify up to 10 symbols:

Cross Equities Long Term Debt To Capitalization Analysis

Compare Assertio Therapeutics and related stocks such as Emergent Biosolutions, Bausch Health Companies, and Neurocrine Biosciences Long Term Debt To Capitalization Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity
201020112012201320142015201620172018201920202021202220232024
EBS0.340.11550.11670.11240.31210.27220.29380.01460.43690.42310.36760.33330.24490.40750.43
BHC1.28920.62010.73920.77030.74140.83660.90450.81180.89810.95870.97811.00471.03521.04891.1
NBIX0.01090.49830.49830.49830.49830.49830.49830.49830.44690.22010.22010.19610.19610.180.14
TEVA0.33470.31560.33970.31520.26870.21970.49380.62420.64480.63740.69390.67780.70750.70760.74
HLN(0.0139)(0.0139)(0.0139)(0.0139)(0.0139)(0.0139)(0.0139)(0.0139)(0.0139)(0.0139)(0.0156)(0.0108)0.37710.34410.36
TAK0.00550.13640.21240.22190.22750.21690.24050.33040.48020.48820.47140.42150.38880.3810.4
ITCI0.97810.97810.97810.97810.97810.97810.97810.97810.97810.97810.97810.97810.97810.880.78
CTLT1.15321.15321.18291.16070.74550.74240.73960.70910.63160.49280.44710.46520.4820.5740.8
AMPH0.0640.0640.0640.03850.11360.09260.08950.1080.08780.09190.0770.14310.12110.47960.5
ALVO(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)(1.8731)1.51664.1315(89.0177)(84.57)

Assertio Therapeutics and related stocks such as Emergent Biosolutions, Bausch Health Companies, and Neurocrine Biosciences Long Term Debt To Capitalization description

My Equities

My Current Equities and Potential Positions

Assertio Therapeutics
ASRT
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
LocationIllinois; U.S.A
ExchangeNASDAQ Exchange
USD 0.93

Additional Tools for Assertio Stock Analysis

When running Assertio Therapeutics' price analysis, check to measure Assertio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Assertio Therapeutics is operating at the current time. Most of Assertio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Assertio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Assertio Therapeutics' price. Additionally, you may evaluate how the addition of Assertio Therapeutics to your portfolios can decrease your overall portfolio volatility.